RSBN1
Lysine-specific demethylase 9
Also known as: FLJ11220, ROSBIN, RSBN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5VWQ0
- Gene
- RSBN1
- Ensembl
- ENSG00000081019
- Chromosome
- 1
- Canonical length
- 802 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable histone H4K20 demethylase activity and metal ion binding activity. Predicted to be involved in chromatin remodeling. Predicted to be located in endoplasmic reticulum. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
802 residues, UniProt reviewed canonical sequence.
>Q5VWQ0|RSBN1
1 MFISGRRTAD KWRAEERLQC PAGSARAALA RCADGGAVGP FKCVFVGEMA AQVGAVRVVR
61 AVAAQEEPDK EGKEKPHAGV SPRGVKRQRR SSSGGSQEKR GRPSQEPPLA PPHRRRRSRQ
121 HPGPLPPTNA APTVPGPVEP LLLPPPPPPS LAPAGPAVAA PLPAPSTSAL FTFSPLTVSA
181 AGPKHKGHKE RHKHHHHRGP DGDPSSCGTD LKHKDKQENG ERTGGVPLIK APKRETPDEN
241 GKTQRADDFV LKKIKKKKKK KHREDMRGRR LKMYNKEVQT VCAGLTRISK EILTQGQINS
301 TSGLNKESFR YLKDEQLCRL NLGMQEYRVP QGVQTPFMTH QEHSIRRNFL KTGTKFSNFI
361 HEEHQSNGGA LVLHAYMDEL SFLSPMEMER FSEEFLALTF SENEKNAAYY ALAIVHGAAA
421 YLPDFLDYFA FNFPNTPVKM EILGKKDIET TTISNFHTQV NRTYCCGTYR AGPMRQISLV
481 GAVDEEVGDY FPEFLDMLEE SPFLKMTLPW GTLSSLRLQC RSQSDDGPIM WVRPGEQMIP
541 TADMPKSPFK RRRSMNEIKN LQYLPRTSEP REVLFEDRTR AHADHVGQGF DWQSTAAVGV
601 LKAVQFGEWS DQPRITKDVI CFHAEDFTDV VQRLQLDLHE PPVSQCVQWV DEAKLNQMRR
661 EGIRYARIQL CDNDIYFIPR NVIHQFKTVS AVCSLAWHIR LKQYHPVVEA TQNTESNSNM
721 DCGLTGKREL EVDSQCVRIK TESEEACTEI QLLTTASSSF PPASELNLQQ DQKTQPIPVL
781 KVESRLDSDQ QHNLQEHSTT SVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RSBN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 28 nTPM
- retina: 12 nTPM
- thymus: 11 nTPM
- cerebellum: 10 nTPM
- ovary: 10 nTPM
- pancreas: 9.5 nTPM
Single-cell type
- neutrophils: 286 nCPM
- neutrophil progenitors: 210 nCPM
- t-cells: 133 nCPM
- innate lymphoid cells: 127 nCPM
- lactotrophs: 104 nCPM
- megakaryocyte-erythroid progenitors: 98 nCPM
Immune cell
- basophil: 51 nTPM
- naive B-cell: 33 nTPM
- memory B-cell: 32 nTPM
- naive CD4 T-cell: 32 nTPM
- memory CD4 T-cell: 31 nTPM
- T-reg: 30 nTPM
Brain region
- cerebellum: 34 nTPM
- hypothalamus: 19 nTPM
- white matter: 19 nTPM
- basal ganglia: 18 nTPM
- cerebral cortex: 17 nTPM
- thalamus: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 2.11
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RSBN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RSBN1 as an antibody target. Whether an autoantibody or antibody against RSBN1 could matter depends on whether native RSBN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RSBN1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RSBN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...